0001140361-17-038676.txt : 20171013 0001140361-17-038676.hdr.sgml : 20171013 20171013193517 ACCESSION NUMBER: 0001140361-17-038676 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160606 FILED AS OF DATE: 20171013 DATE AS OF CHANGE: 20171013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWLIS V BRYAN CENTRAL INDEX KEY: 0001247681 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 171137412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4/A 1 doc1.xml FORM 4/A X0306 4/A 2016-06-06 2016-06-08 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001247681 LAWLIS V BRYAN C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 0 0 0 Common Stock 2016-06-06 2016-06-06 4 J 0 0 0 A 13360 D On June 8, 2016, the reporting person filed a Form 4 which inadvertently reported an incorrect total amount of securities beneficially owned following the reported transaction. This amendment corrects such total. /s/ Laura Randall Woodhead, Attorney-in-Fact 2017-10-13